![Estela Rodriguez: Racial disparities in early-stage NSCLC treatment: A Call for Action](https://oncodaily.com/pub/uploads/2023/06/Dr.-Estela-Rodriguez-1-e1713808611574-1280x821.jpeg)
Estela Rodriguez: Racial disparities in early-stage NSCLC treatment: A Call for Action
Estela Rodriguez shared on X/Twitter:
“Racial disparities in early-stage Non-Small Cell Lung Cancer (NSCLC) treatment: A Call for Action. Great to see Qinran Liu, UM Public Health Science‘s work using FL population-based cancer registry highlighted in Cancer Epidemiology, Biomarkers and Prevention.”
Additional information.
Source: Estela Rodriguez/X
Estela Rodriguez is Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. She is board certified in medical oncology and hematology. She has a special interest in the early detection of lung cancer and increasing access to clinical trials. Dr. Rodriguez is known to help empower women to take charge of their own healthcare and believes in the power of mentorship.
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”